4 completed, 1 recruiting. 5 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Dementia of Alzheimer Type: new trials by email Literature Review of Dementia of Alzheimer Type trials Research Report on Dementia of Alzheimer Type
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DMB-I in the Treatment of Alzheimer Type Dementia DMB-I (Dimebon), Placebo - Alzheimer Disease, Dementia of Alzheimer Type | Phase 2 | Completed | Bigespas LTD | 133 | 2023-12-27 | 2025-03-28 |
| Assess Fibrin in Brains With AD/ADRD PET/MR Imaging, 64Cu-FBP8 - Alzheimer Disease, Dementia of Alzheimer Type | Phase 1 / Phase 2 | Recruiting | Massachusetts General Hospital | 30 | 2022-03-29 | 2025-10-30 |
| A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease ATH-1017, Placebo - Alzheimer Disease, Dementia of Alzheimer Type | Phase 2 | Completed | LeonaBio | 77 | 2020-11-23 | 2023-06-12 |
| ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease ATH-1017, Placebo - Alzheimer Disease, Dementia of Alzheimer Type | Phase 2 / Phase 3 | Completed | LeonaBio | 554 | 2020-09-28 | 2025-04-04 |
| Treating Hyperexcitability in AD With Levetiracetam Levetiracetam, Placebo oral capsule - Alzheimer Dementia, Alzheimer Disease | Phase 2 | Completed | Beth Israel Deaconess Medical Center | 58 | 2019-08-22 | 2026-04-07 |
Alzheimer Disease (5) · Dementia (3) · Cognitive Dysfunction (1) · Memory Disorders (1)
Brain Diseases (5) · Central Nervous System Diseases (5) · Mental Disorders (5) · Nervous System Diseases (5) · Neurocognitive Disorders (5) · Neurodegenerative Diseases (5) · Tauopathies (5) · Dementia (2) · Cognition Disorders (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Levetiracetam (1) · Magnetic Resonance Imaging (1) · Positron-Emission Tomography (1) · latrepirdine (1)
LeonaBio (2) · Beth Israel Deaconess Medical Center (1) · Bigespas LTD (1) · Massachusetts General Hospital (1)
United States (4) · Australia (1) · Russia (1)
Ciprian Catana, MD, PhD (1) · Javier San Martin, MD (1)
PMID 38599894, PMID 41313764, PMID 41574278, PMID 42141012
R01AG068268 (1), R01HL109448 (1)